INGENITO GARY 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Dec 11, 2024
Insider Transaction Report
Form 4
INGENITO GARY
Chief Med. & Reg. Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-12-09−7,349→ 1,034,282 total→ Common Stock (7,349 underlying) - Exercise/Conversion
Common Stock, par value $0.001 per share
2024-12-09+7,349→ 58,740 total - Tax Payment
Common Stock, par value $0.001 per share
2024-12-09−2,891→ 55,849 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
- [F3]Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 9, 2024.